| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2018 | Apr 3, 2018 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 15.0 | -1,114 | -100.00% | ✓ | $556.3 |
| Feb 27, 2018 | Mar 1, 2018 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 30.0 | -161 | -12.63% | ✓ | $85.3 |
| Apr 3, 2017 | Apr 5, 2017 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 15.0 | -1,114 | -46.63% | ✓ | $2.7K |
| Feb 27, 2017 | Mar 1, 2017 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 37.5 | -161 | -6.31% | ✓ | $412.2 |
| Sep 19, 2016 | Sep 21, 2016 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 25.0 | -476 | -15.73% | ✓ | $1.4K |
| Apr 4, 2016 | Apr 6, 2016 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 15.0 | -1,114 | -26.91% | ✓ | $3.9K |
| Feb 29, 2016 | Mar 2, 2016 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 42.5 | -160 | -3.72% | ✓ | $553.6 |
| Sep 18, 2015 | Sep 21, 2015 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 33.8 | -476 | -9.97% | ✓ | $3K |
| Mar 2, 2015 | Mar 2, 2015 | Oruka Therapeutics, Inc. | VP, Finance | Sell | 42.5 | -1,125 | -3.25% | ✓ | $799.9 |